Hide Board Information

Show Board Information

ReliaBrand Inc. RLIA

Board Mod: John Howard

Asst Mods:

Last Post: 07/16/2014 7:00:20 PM

Board Marks: 5

Posts Today: 0

Board Views Today: 3

ReliaBrand Inc. (OTCMRKTS: RLIA) Stock Message Board

1. RLIA Company Profile

    

2. RLIA Time & Sales

    

3. RLIA Recent News

    

4. RLIA Filings

    

5. RLIA Financials

    

6. RLIA Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

13	RLIA Money Maker	theellasmith	12/19/2012 9:21:11 AM
12	Looks g	John Howard	12/19/2012 9:09:44 AM
11	They ha	John Howard	12/19/2012 9:06:24 AM
10	I must	duncanluger	12/19/2012 8:57:04 AM
9	Also, m	duncanluger	12/19/2012 7:12:42 AM
8	It is g	duncanluger	12/19/2012 7:05:47 AM
7	Online	duncanluger	12/19/2012 6:45:52 AM
6	RLIA news and awards!	John Howard	12/19/2012 6:21:59 AM
5	ReliaBr	Mary Johnson	12/19/2012 6:19:43 AM
4	Corpora	Mary Johnson	12/19/2012 6:19:16 AM
3	E-store	Mary Johnson	12/19/2012 6:16:40 AM
2	Home of	Mary Johnson	12/19/2012 6:16:18 AM
1	Business Description ReliaBrand is a newly formed	Mary Johnson	12/19/2012 6:14:42 AM

Newer

Recent Articles

• Discovering the Future: Europe's Top Urban Centers for 2025
• Mitsubishi Motors Introduces New Electric Vehicle for North America
• Revolutionizing Travel: Bhutan Unveils Crypto Tourism Payments
• CLINUVEL Completes Enrollment in Groundbreaking Vitiligo Study
• Understanding Recent Bitcoin Volatility Trends with Bybit
• Revolutionizing Maritime AI through Innovative Partnerships
• Empowering Future Farmers: Microsoft and FFA's Innovative Program
• Grant Industries Partners with Labbit for Enhanced Digital Solutions
• NetDragon Leads the Charge in Digital Innovation and Learning
• Empowering Climate Finance: Launch of GCBC Accelerator Initiative
• GCBC Accelerator Launch: Advancing Climate Finance Solutions
• ISC Reports Robust Q1 Performance with Significant Growth
• ISC Announces Quarterly Dividend, Strengthens Financial Position
• Community Efforts Shine During ALS Awareness Month Advocacy
• Caplight's Innovative Patent Sets New Standards in Pricing Transparency
• Revolutionizing Animation Production: CreateAI's Insights Revealed
• Revolutionizing Electric Vehicles: HIGHLY's Thermal Solutions
• LONGi and ENGIE Team Up to Elevate Solar Energy Standards
• Liberty Energy Solutions to Acquire PEC Ltd. for US$160 Million
• TIER IV Leads the Charge in Autonomous Driving Standards
• An Unforgettable Evening with Shatner and Tyson: Join Us!
• Karat Packaging Board Approves Regular Dividend for Shareholders
• Civitas Resources Inc. Faces Class Action Lawsuit for Misleading
• Exploring the Lucrative HALS Market Growth Projections
• Empowering Future Leaders: Dr. Austin Harris's Grant
• Empowering Future Sports Professionals with a New Scholarship
• Innovative Research on Nucleic Acid Technologies by Ajinomoto
• Innovative Advances in Cancer Therapy by CStone Pharmaceuticals
• Innovent Launches First Patient Dosing for New DME Treatment
• Innovative Research Boosts Aptamer Technology by Ajinomoto
• Fidelity D & D Bancorp Declares Q2 2025 Dividend Payment
• Teamsters at Seattle Airport Vote to Strike Against Swissport
• Empowering Tomorrow's Real Estate Leaders Through Education
• California's Bill AB 446 Aims to Protect Consumers from Pricing Abuse
• Veltex Corporation Expands Board with New Strategic Leaders
• Bellroy Unveils Innovative Luggage Solutions for Travel Enthusiasts
• Propelis Emerges as a Major Brand Agency Powerhouse
• MPLX and Enbridge Join Forces on Matterhorn Express Pipeline
• Edgewood Monuments Expands Custom Memorial Services Across USA
• Allied Properties' Latest Unitholder Meeting Unveils Key Decisions
• Insightful Analysis of Overspending in Police Overtime
• Investigation Launched for Investors of Take-Two Software
• Adcentrx Therapeutics Accelerates Development of ADRX-0706
• Montage Gold Expands Influence in Côte d’Ivoire Gold Sector
• Osisko Development's Q1 2025 Results: Growth and Progress Insights
• Ardelyx, Inc. Faces Investigation After Financial Shortfall
• Veterans' Impact Highlighted at Washington Hearing with Independence Fund
• Integra LifeSciences Faces Investigation Over Financial Discrepancies
• Investigation of PTC Therapeutics: Examining Investor Claims
• Strong Performance Declared by IRSA for Third Quarter 2025